Showing results (241-250 of 300) with videos related to

Sort By:
Pageof 30
NPJ Precision Oncology|September 30, 2024
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancerJingyuan Wang, Joanne Xiu, Francesca Battaglin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2017
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA StudyJianming Xu, Tae Won Kim, Lin Shen, et al.
Innovation (Cambridge (Mass.))|January 28, 2025
Famitinib plus camrelizumab in patients with advanced colorectal cancer: Data from a multicenter, basket studyLuoyan Ai, Qian Li, Shilong Zhang, et al.
Journal for Immunotherapy of Cancer|February 22, 2024
First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1%: results from a multicenter, open-label, phase 2 trialShengxiang Ren, Xicheng Wang, Bao-Hui Han, et al.
The Lancet. Oncology|May 19, 2015
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trialJin Li, Shukui Qin, Ruihua Xu, et al.
International Journal of Cancer|May 26, 2023
Quantitative analysis of a novel DNA hypermethylation panel using bronchial specimen for lung cancer diagnosisMaosen Dou, Dan Li, Mengchan Zhu, et al.
BMC Cancer|June 30, 2017
CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT<sub>3-4a</sub>N<sub>0-1</sub>M<sub>0</sub>) (NCT03001596)Han Tang, Lijie Tan, Yaxing Shen, et al.
Journal of Hematology & Oncology|May 8, 2026
Chinese guidelines for HER2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma (2025 Edition)Xiaotian Zhang, Yakun Wang, Muyan Cai, et al.
European Journal of Preventive Cardiology|November 13, 2025
Polygenic prediction of coronary heart disease among 130,000 Mexican adultsTianshu Liu, Jaime Berumen, Jason Torres, et al.
BMC Medicine|October 25, 2022
Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trialDan Liu, Jun Zhou, Yongsheng Wang, et al.
Pageof 30